Introduction: WD is an autonomic recessive disorder caused by mutations in the ATP7Bgene, characterized by dramatic of hepatic accummulations of hepatic copper, with subsequent hepatic and neurologic abnormalities. Electron mycroscopy has been decisive for Wilson's disease precocious diagnosis. Three stages have been morphologically identified depending on mitochondrial and lisosomal damage. Wilson's disease early diagnosis is very important because it enables the application of an adequate therapy and avoids fatal outcomes. Objective: To study the fine structure of WD hepatic tissue in order to improve the morfologic criteria for early diagnosis. Materials and methods: Samples of hepatic biopsies from 18 adult patients (males and females) clinically suspicious of WD were studied. Biopsies were obtained by laparoscopy and divided into three fragments: for optical and electron microscopy and for tissue determination of copper. Results: In all cases the liver copper content was increased and WD was confirmed clinically. At optical microscope 10 out of the 18 cases showed morphological alterations compatible with WD; 6 of them showed ultrastructural features typical of WD. The other 8 (of the 18) were diagnosed as normal under the optical microscope, but 6 of them presented outstanding mitochondrial alterations, among them the three typical kinds of intramitochondrial inclusions. The latter was determinant for the early diagnosis of WD. Conclusions: Electron microscopy is highly valuable for Wilson's disease early diagnosis, especially for those patients whose biopsies do not show histologic alterations visible at the optical microscope.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.